Advanced Micro Devices - Stock Analyst Research

Target Price* 190.00
Recommendation BUY
Market Cap*-
Publication Date6 May 2024

*At the time of publication

Advanced Micro Devices Inc. - More demand for AI

  • 1Q24 results were slightly below expectations due to weaker Gaming and Embedded segments. 1Q24 revenue/PATMI was at 20%/4 % of our FY24e estimates. We expect both revenue and PATMI to be backloaded into 2H24e as the MI300x ramp-up continues and Embedded recovers.
  • MI300x demand is still strong, with AMD increasing FY24e sales to >US$4bn on better supply visibility. Customers are seeing better inferencing performance in MI300x vs. Nvidia’s H100. AMD is also seeing very strong demand for its Ryzen 8000 Series CPUs as OEMs like Acer, HP, etc. began ramping their new notebook designs.
  • We lower our FY24e revenue/PATMI by 4%/6% due to prolonged weakness in Gaming and Embedded, offset slightly by higher DC + PC demand. We lower our target price to US$190 (prev. US$195) while keeping our WACC/growth rate assumptions of 7.4%/5% unchanged. Due to recent price movements, we upgrade to a BUY from ACCUMULATE. We believe AMD will benefit from increasing AI-related investments while also gaining traditional server market share from enterprise transition to the Cloud. We also see significant market share gains in PC due to its strong CPU product line.

 

 

The Positives

+ DC growth supported by strong MI300x ramp-up and server CPU gains. 1Q24 was the first full quarter of MI300x sales (~US$600mn) as customer demand for AMD’s AI GPUs remained strong. MI300x deployments expanded at Microsoft, Meta, and Oracle, with customer feedback of better inferencing performance vs. Nvidia’s H100. AMD raised its FY24e GPU revenue to >US$4bn (prev. >US$3.5bn) on improving demand-supply dynamics, which we estimate equates to roughly US$300mn additional ramp per quarter. Server CPU (EPYC) growth is also doing well (est. ~25% YoY), with enterprise customers beginning their server refresh cycle and expanding cloud and on-premise deployments. EPYC adoption is accelerating due to higher efficiency and cost savings (~45%) vs. competitors, with AMD gaining market share. AMD guided strong YoY growth for GPU and CPU sales in 2Q24e.

 

+ Early signs of PC upgrading cycle with strong demand for Ryzen 8000 CPUs. AMD’s PC segment grew to 85% YoY (4Q23: 62% YoY), significantly quicker than main competitor Intel (31% YoY). Demand from OEMs picked up, with desktop CPU sales growing strong double-digits YoY and laptop CPU sales almost doubling. AMD is anticipating growth in the PC market for 2024 due to 1) early signs of a refresh cycle from enterprises, and 2) increasing AI PC adoption. AMD guided its PC segment to increase QoQ, and significantly YoY due to higher volume and ASPs.

 

The Negative

– Gaming is still a huge drag, with Embedded recovery delayed. Gaming and Embedded were both down ~50% YoY, with Gaming still weak due to its 5th year in the console cycle and customer inventory still elevated. AMD expects weakness in Gaming to continue significantly into 2H24e. Embedded’s -46% YoY decline was more than expected due to weaker demand from the communications, industrial, and automotive sectors. The overall segment looks to have bottomed, although AMD expects the recovery to be more moderate. Recovery in the Embedded segment will be a tailwind to overall margins (1Q24 Adj. Operating Margin: 40%).

About the author

Jonathan Woo
Research Analyst
PSR

Jonathan covers the US technology sector focusing on internet companies. Formerly a national and professional athlete, he graduated from the University of Oregon with a Bachelor’s Degree in Social Sciences.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com